DarioHealth (DRIO) Competitors $0.80 +0.06 (+8.09%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DRIO vs. MGRM, ECOR, LNSR, EDAP, VANI, NSPR, HYPR, APYX, MLSS, and OMShould you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Monogram Orthopaedics (MGRM), electroCore (ECOR), LENSAR (LNSR), Edap Tms (EDAP), Vivani Medical (VANI), InspireMD (NSPR), Hyperfine (HYPR), Apyx Medical (APYX), Milestone Scientific (MLSS), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. DarioHealth vs. Monogram Orthopaedics electroCore LENSAR Edap Tms Vivani Medical InspireMD Hyperfine Apyx Medical Milestone Scientific Outset Medical DarioHealth (NASDAQ:DRIO) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership. Which has more volatility and risk, DRIO or MGRM? DarioHealth has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 2, indicating that its stock price is 100% more volatile than the S&P 500. Do analysts rate DRIO or MGRM? DarioHealth presently has a consensus target price of $4.00, indicating a potential upside of 400.00%. Monogram Orthopaedics has a consensus target price of $4.00, indicating a potential upside of 55.04%. Given DarioHealth's higher possible upside, equities research analysts clearly believe DarioHealth is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DarioHealth 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has better earnings & valuation, DRIO or MGRM? Monogram Orthopaedics has lower revenue, but higher earnings than DarioHealth. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDarioHealth$23.05M1.18-$59.43M-$0.94-0.85Monogram Orthopaedics$365.00K242.53-$13.74M-$0.47-5.49 Does the media refer more to DRIO or MGRM? In the previous week, Monogram Orthopaedics had 4 more articles in the media than DarioHealth. MarketBeat recorded 5 mentions for Monogram Orthopaedics and 1 mentions for DarioHealth. DarioHealth's average media sentiment score of 1.08 beat Monogram Orthopaedics' score of 0.36 indicating that DarioHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Monogram Orthopaedics 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in DRIO or MGRM? 33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are owned by institutional investors. 16.5% of DarioHealth shares are owned by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor DRIO or MGRM? DarioHealth received 236 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 100.00% of users gave Monogram Orthopaedics an outperform vote while only 67.04% of users gave DarioHealth an outperform vote. CompanyUnderperformOutperformDarioHealthOutperform Votes23867.04% Underperform Votes11732.96% Monogram OrthopaedicsOutperform Votes2100.00% Underperform VotesNo Votes Is DRIO or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to DarioHealth's net margin of -205.62%. DarioHealth's return on equity of -72.16% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets DarioHealth-205.62% -72.16% -40.74% Monogram Orthopaedics N/A -130.90%-106.38% SummaryMonogram Orthopaedics beats DarioHealth on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get DarioHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRIO vs. The Competition Export to ExcelMetricDarioHealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.28M$4.34B$5.13B$9.08BDividend YieldN/A41.46%4.91%4.22%P/E Ratio-0.8525.3791.4117.18Price / Sales1.1845.961,113.72116.79Price / CashN/A43.4542.7137.86Price / Book0.377.364.794.78Net Income-$59.43M$13.64M$120.07M$225.60M7 Day Performance9.32%-2.86%-1.92%-1.23%1 Month Performance-1.54%0.50%11.46%3.36%1 Year Performance-51.22%41.87%30.49%16.59% DarioHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRIODarioHealth2.2562 of 5 stars$0.80+8.1%$4.00+400.0%-50.9%$27.28M$23.05M-0.85200News CoveragePositive NewsHigh Trading VolumeMGRMMonogram Orthopaedics3.2379 of 5 stars$2.76+3.8%$4.00+44.9%-24.1%$94.70M$364,999.00-5.6628Gap DownECORelectroCore2.6029 of 5 stars$14.15+4.0%N/A+164.2%$92.75M$23.33M-7.4450Analyst ForecastAnalyst RevisionNews CoverageLNSRLENSAR0.5658 of 5 stars$7.53-0.3%$8.00+6.2%+191.7%$87.46M$48.87M-5.17110News CoverageEDAPEdap Tms3.2811 of 5 stars$2.22+0.9%$19.00+755.9%-56.2%$82.37M$63.41M-3.38307VANIVivani Medical2.7967 of 5 stars$1.31flat$3.00+129.0%+34.6%$77.60MN/A-2.9120News CoveragePositive NewsNSPRInspireMD2.1978 of 5 stars$2.97+0.7%$4.75+59.9%+45.6%$77.47M$6.82M-3.9350Analyst ForecastGap UpHYPRHyperfine2.283 of 5 stars$0.97-3.0%$1.60+64.9%-15.7%$70.76M$13.26M-1.75190APYXApyx Medical1.6647 of 5 stars$1.78+6.0%N/A-37.2%$67.01M$48.54M-2.23270Positive NewsMLSSMilestone Scientific1.4761 of 5 stars$0.84+3.7%$1.25+48.8%+54.0%$65.43M$8.88M-11.5730Analyst ForecastNews CoverageOMOutset Medical2.5559 of 5 stars$1.10-1.4%$4.50+311.0%-79.0%$57.53M$130.38M0.00520Positive NewsGap Up Related Companies and Tools Related Companies MGRM Alternatives ECOR Alternatives LNSR Alternatives EDAP Alternatives VANI Alternatives NSPR Alternatives HYPR Alternatives APYX Alternatives MLSS Alternatives OM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DRIO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
